IP Library Granted Patent US 10,722,715
Granted Patent B2
US 10,722,715 · App. 15/854,206 · Granted Jul 28, 2020

Systems and methods for the treatment of pain through neural fiber stimulation

Inventors: Maria E. Bennett (Beachwood, OH); Joseph W. Boggs (Chapel Hill, NC); Warren M. Grill (Chapel Hill, NC); John Chae (Strongsville, OH)
Assignee: SPR Therapeutics, Inc.
A61N1/36071A61N1/36003A61N1/36017A61N1/36021A61N1/36057
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,722,715
App. No.
15/854,206
Granted
Jul 28, 2020
Kind
B2
Abstract

Embodiments of the present invention provide systems and methods for the treatment of pain through activation of select neural fibers. The neural fibers may comprise one or more afferent neural fibers and/or one or more efferent neural fibers. If afferent fibers are stimulated, alone or in combination with efferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate afferent pathways in a manner approximating natural afferent activity. The afferent fibers may be associated with primary receptors of muscle spindles, golgi tendon organs, secondary receptors of muscle spindles, joint receptors, touch receptors, and other types of mechanoreceptors and/or proprioceptors. If efferent fibers are stimulated, alone or in combination with afferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate intrafusal and/or extrafusal muscle fibers, which results in an indirect activation of afferent fibers associated therewith.

Claims (14)

1. A method comprising the steps of:

percutaneously inserting a single contact electrode operatively coupled with a lead in-vivo in a patient a therapeutically effective distance from a target efferent nerve fiber, wherein the therapeutically effective distance comprises 1 mm;

electrically stimulating through the lead and electrode the target efferent nerve fiber to generate an action potential in the target efferent nerve fiber while avoiding generation of action potentials in a small sensory nerve fiber to generate or modulate response afferent activity by contracting muscle fibers to reduce pain in the patient.

2. The method of claim 1 , wherein the target efferent nerve fibers comprise motor axons.

3. The method of claim 1 further comprising activation of intrafusal or extrafusal muscle fibers.

4. A method of reducing a perception of pain, the method comprising the steps of:

percutaneously inserting an electrode into a patient;

positioning the electrode at a therapeutically effective distance from a target efferent nerve fiber;

electrically stimulating through the electrode to the target efferent nerve fiber to generate an action potential in the target efferent nerve fiber while avoiding generation of action potentials in Type III and Type IV afferent nerve fibers; and

removing the electrode, wherein pain relief is generally maintained for a time after removal.

5. The method of claim 4 , wherein the electrode is a single contact electrode.

6. A method of reducing a perception of pain, the method comprising:

percutaneously inserting a single contact electrode in at least one of muscle, subcutaneous, connective or adipose tissue located near a nerve trunk upstream from a region of pain a patient; and

electrically stimulating through the single contact electrode by an electrical stimulator to a plurality of target efferent motor nerve fibers to generate an action potential in the plurality of target efferent motor nerve fibers while avoiding generation of action potentials in small sensory nerve fibers.

Assignments (4)
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: SLR INVESTMENT CORP., AS AGENT
Reel/Frame 066381/0075 →
SECURITY INTEREST Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: GEMINO HEALTHCARE FINANCE, LLC
Reel/Frame 066412/0400 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 26, 2017
From: BENNETT, MARIA E.; BOGGS, JOSEPH W.; GRILL, WARREN M.; CHAE, JOHN
To: SPR THERAPEUTICS, LLC
Reel/Frame 044484/0573 →
CHANGE OF NAME Recorded Dec 26, 2017
From: SPR THERAPEUTICS, LLC
To: SPR THERAPEUTICS, INC.
Reel/Frame 044959/0799 →